Spondylolysis and Spondylolisthesis:

A Case Based Discussion of Contemporary Treatment Guidelines Based on Evidence

Presented by the Scoliosis Research Society

Chair: Charles Crawford III, MD

Saturday, August 18th, 2018 at 10:00am CT

Upon completion of this webinar, participants should be able to:

 Identify commonly encountered clinical treatment of Spondylolysis and Spondylolithesis.

 Recognize scenarios of the pediatric population and of symptomatic disease in the adult.
 Detect non-operative and operative treatment options

Agenda

Introduction – Charles Crawford III, MD

Case Based Presentation of Pediatric Spondylolysis- Charles Crawford III, MD

Case of Pediatric Low Grade Isthmic Spondylolisthesis- John Dimar II, MD

Case of Pediatric High Grade Isthmic Spondylolisthesis- Suken Shah, MD

Case of Adult Isthmic Spondylolisthesis- Gregory Mundis, MD

Questions and Answer

This activity has been planned and implemented in accordance with the Essential Areas and Policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the
Scoliosis Research Society (SRS). SRS is accredited by the ACCME to provide continuing medical
education for physicians.

The Scoliosis Research Society (SRS) designates this web activity for a maximum of 1 AMA PRA Category
1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in
the activity.

This webinar is free to members and non-members.

Disclosed Conflicts of Interest

Faculty

Charles Crawford III, MD- Alphatec Spine (b,d,g); Medtronic (a); ISSG (a); Pfizer (a); Intellirod (a)

John Dimar II, MD- DePuy Synthes (b); Medtronic (b,g)

Gregory Mundis, MD- Nuvasive (b,e,g); K2M (b,g); Allosource (e)

Suken Shah, MD- DePuy Synthes (a,b,e,g); NuVasive (b); K2M (a,g); Globus Medical (g); Setting Scoliosis
Straight Foundation (a,e)